PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 109
- Registration Number
- NCT04435769
- Locations
- 🇨🇿
Fakultní nemocnice Motol, Praha 5, Czechia
Global Prevalence of ATTR-CM in Participants With HFpEF
- Conditions
- Heart Failure With Preserved Ejection FractionTransthyretin Amyloid Cardiomyopathy
- Interventions
- Diagnostic Test: Scintigraphy
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 347
- Registration Number
- NCT04424914
- Locations
- 🇺🇸
Advance Medical Research Center, Miami, Florida, United States
🇺🇸Bioclinical Research Alliance Inc., Miami, Florida, United States
🇺🇸Biogenix Molecular, Miami, Florida, United States
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1493
- Registration Number
- NCT04428424
- Locations
- 🇮🇶
Pfizer, Baghdad, Iraq
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 486
- Registration Number
- NCT04428411
- Locations
- 🇮🇶
Pfizer, Baghdad, Iraq
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 127
- Registration Number
- NCT04428502
- Locations
- 🇮🇶
Pfizer, Baghdad, Iraq
Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 8
- Registration Number
- NCT04427917
- Locations
- 🇧🇪
Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium
Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 280
- Registration Number
- NCT04424303
- Locations
- 🇫🇷
Clinique de l Europe, Amiens, France
🇫🇷Hopital D'Estaing, Clermont Ferrand, France
🇫🇷Hopital Sud, Amiens, France
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
- Conditions
- Respiratory Tract Infection
- Interventions
- Biological: Placebo
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 14727
- Registration Number
- NCT04424316
- Locations
- 🇺🇸
Pocatello Women's Health Clinic, Pocatello, Idaho, United States
🇺🇸1st Choice Urgent Care, Pocatello, Idaho, United States
🇺🇸The Iowa Clinic, Ankeny, Iowa, United States
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2023-04-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 460
- Registration Number
- NCT04413617
- Locations
- 🇧🇬
Independent Medical Diagnostic Laboratory Mediscan EOOD, Plovdiv, Bulgaria
🇧🇬MHAT Plovdiv AD, Plovdiv, Bulgaria
🇧🇬DCC Sveti Georgi EOOD, Plovdiv, Bulgaria
Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
- First Posted Date
- 2020-06-02
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Pfizer
- Registration Number
- NCT04412252
- Locations
- 🇺🇸
LSUHSC-Shreveport, Shreveport, Louisiana, United States
🇺🇸Ochsner LSU Health Shreveport Academic Medical Center, Shreveport, Louisiana, United States
🇺🇸University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States